StocksMedium•5 November 2026•
1 min read
Haemonetics Beats Q2 Fiscal 2027 Earnings Estimates
Key Facts
1Haemonetics reported quarterly earnings of $1.35 per share, beating the Zacks Consensus Estimate of $1.30 per share.
2The current quarter's earnings of $1.35 per share compare to $1.27 per share reported a year ago.
Haemonetics reported quarterly earnings of $1.35 per share for the second quarter of fiscal 2027, beating the Zacks Consensus Estimate of $1.30 per share. According to Zacks, the current results represent growth over the $1.27 per share reported in the same quarter a year ago.
The company achieved a positive earnings surprise of approximately 3.8% relative to consensus estimates, driven by operational performance exceeding prior-year levels. HAE closed at $127.42 on November 4, 2026, following a session that saw a trading range between $121.26 and $128.82.